Destination XL (DXLG) Q1 2026 earnings review
Sales Bleed Slows, But Profitability Remains Elusive
DXL's fiscal 2026 started with signs of stabilization before hitting a wall in April. The severe comparable sales declines of FY25 are decelerating—Q1 total comps fell 3.8% versus a 9.4% drop a year ago. The Direct business was the standout, shrinking its comp decline to just -1.6% from -16.2%. However, this top-line stabilization did not rescue the bottom line. Gross margins compressed by 80 basis points, dragging Adjusted EBITDA into negative territory at $(0.7)M. Management is navigating a brutal cocktail of headwinds: a distracted consumer, GLP-1 weight-loss drug impacts, mounting tariff costs, and the operational complexities of a pending merger with FullBeauty Brands.
🐂 Bull Case
The direct business is reversing its freefall. Boosted by paid search, social, and a replatformed website, the direct channel nearly reached parity YoY (-1.6%), a massive improvement from the double-digit declines seen throughout FY25.
Despite weak demand, inventory is highly disciplined, dropping $4.1M YoY to $81.4M. Clearance inventory remains tightly managed at 9.9%, avoiding the desperate markdown cycles that typically plague struggling apparel retailers.
🐻 Bear Case
Comps improved nicely early in the quarter (-1.3% in Feb, -2.7% in Mar) but suddenly reversed and collapsed to -6.8% in April. Management blamed macro pressures and an early Easter, but the violent intra-quarter swing shows the consumer remains highly fragile.
With sales falling and fixed costs rigid, profitability is evaporating. SG&A deleveraged to 45.0% of sales, and Adjusted EBITDA flipped from positive to negative. Shrinking to greatness is not working.
⚖️ Verdict: 🔴
Bearish. While the deceleration in top-line declines is a relief, the sudden April deterioration and structural margin pressures (tariffs, GLP-1 sizing issues) paint a bleak near-term picture. The pending FullBeauty merger adds massive execution risk to an already struggling core business.
Key Themes
The April Macro Shock
Management's narrative of an 'improving sales performance' is directly contradicted by their own monthly breakdown. While February and March showed an accelerating recovery trend, April suffered a sudden reversal, plunging to a -6.8% comp. The company attributes this to global conflict, fuel costs, and inflation, but it proves that DXL's core value-conscious consumer is highly volatile and quickly retracting discretionary spend.
FiTMAP Yielding Real Results
The proprietary FiTMAP 3D scanning technology has completed its rollout to 188 stores, engaging over 100,000 customers. Management reports this is accelerating key metrics: scanned customers demonstrate stronger conversion, higher average order values, and greater purchase frequency. With exclusivity through 2030, this remains DXL's most defensible moat against mass-market competitors.
GLP-1 Sizing Disruption
Weight-loss medications are causing a structural headwind. DXL admits a 'meaningful portion' of its base is using GLP-1s, causing them to pause purchases during rapid weight loss or size completely out of the Big + Tall category. While DXL hopes to re-engage them when sizes stabilize, there is severe risk these customers permanently migrate to standard-size retailers.
Private Brand Mix Shift
A deliberate shift toward higher-margin private brands is acting as a crucial shock absorber. While overall merchandise margins fell 100 bps due to tariffs and clearance activity, the damage would have been much worse without the favorable unit economics of the private brand portfolio.
Tariff Pressures and the $4M Refund Gamble
Tariffs continue to act as a tax on gross margin. The company submitted a $4.0M refund claim to U.S. Customs and Border Protection through a new online portal, but realization is highly uncertain. Excluding any refunds, tariffs are expected to shave 100 bps off gross margin for the full year.
AI Integration for Search
As the e-commerce landscape shifts toward conversational search, DXL is investing heavily in AI. They launched new initiatives to enrich item-level attributes and product data quality to ensure high discoverability on AI-enabled platforms, aiming to capture demand early in the digital shopping journey.
Other KPIs
Decelerating. Down 80 bps YoY from 45.1%. The underlying merchandise margin actually dropped 100 bps due to tariffs and shipping surcharges. The total gross margin decline was partially masked by a $1.4M windfall from an early lease termination, which artificially improved the occupancy cost ratio.
Improving. Cash burn from operations narrowed from $(12.0)M in 25Q1, driven by tighter working capital management and disciplined inventory receipts, though lower earnings remain a structural drag on cash generation.
A direct hit to the income statement stemming from the pending FullBeauty Brands merger. This represents over 1% of total sales and significantly contributed to the expanded net loss for the quarter.
Guidance
Accelerating slightly vs expectations. Management lowered their estimate of the tariff hit from a previous forecast of 150 basis points. However, this assumes no new trade laws are enacted.
Stable to decelerating. Down from the 6.5% run rate seen in 26Q1, indicating management will tighten the belt on ad spend for the remainder of the year to protect profitability.
Decelerating drastically. The company has officially paused new store development to preserve cash. CapEx will be restricted entirely to converting legacy Casual Male XL stores, relocations, and critical technology projects.
Key Questions
The April Reversal
Comparable sales dropped sharply from -2.7% in March to -6.8% in April. How much of this was genuinely macroeconomic versus a distraction at the store execution level due to the impending FullBeauty merger?
GLP-1 Customer Retention
You noted that customers on GLP-1 medications intend to return once their size stabilizes. What hard data or CRM tracking do you have to prove this, rather than losing them permanently to standard-size national retailers?
Realization of Tariff Refunds
You filed for a $4.0M tariff refund through the CBP portal. What is the historical precedent for receiving these funds, and what timeline are you modeling for potential cash realization?
Direct Channel Profitability
The Direct business showed impressive top-line stabilization (-1.6% comp). However, given the increase in clearance sales and paid marketing to drive this traffic, was the Direct channel actually profitable on a contribution margin basis this quarter?